Kin Health Secures $9M to Empower Patients With Access to Their Own Care Records
Kin Health Lands $9M Funding to Improve Patient Access to Personal Healthcare Data Kin Health, a healthcare technology startup founded by practicing physicians, has announced a $9 million seed funding round aimed at transforming how patients understand and manage their…
CareTrust REIT, Inc. Announces Pricing for Expanded Common Stock Offering
CareTrust REIT, Inc. Prices Enlarged Public Common Stock Offering CareTrust REIT, Inc. has announced the pricing of an enlarged underwritten public offering of its common stock, a move expected to generate approximately $509.4 million in gross proceeds through a forward…
Improving Mental Health Access Must Be Matched by Better Quality Care
Why access and outcomes must evolve together in mental health care Mental health care in the United States is at a critical moment. Nearly one in four adults experiences a mental health condition each year, yet many still struggle to access…
IHH Healthcare Malaysia Showcases LungShield Programme at 79th World Health Assembly
Geneva participation highlights Malaysia’s public-private partnership model for early detection and occupational lung health IHH Healthcare Malaysia joined lung health discussions held alongside the 79th World Health Assembly in Geneva, bringing Malaysia’s public-private partnership model to a global platform focused…
Microbot Medical to Host Investor Call Featuring LIBERTY System Users Dr. Briggs and Dr. Bercu
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu Microbot Medical Inc., developer and distributor…
NEJM Publishes Shionogi Study Showing Ensitrelvir Prevents COVID-19 After Exposure
NEJM Publishes Shionogi Phase 3 SCORPIO-PEP Study Showing Ensitrelvir Significantly Reduces COVID-19 Risk After Exposure Shionogi & Co., Ltd. announced that results from its global Phase 3 clinical trial, SCORPIO-PEP, evaluating the investigational oral antiviral ensitrelvir for post-exposure prophylaxis (PEP)…
Cord for Life® Achieves Milestone with First Non-Transplant Cord Blood Stem Cell Trial for Lower Back Pain
Cord for Life® Completes Historic Phase 1 Clinical Trial Exploring Cord Blood Stem Cell Therapy for Lower Back Pain Cord for Life®has announced the successful completion of Phase 1 enrollment and dosing in a groundbreaking clinical trial investigating the use…
Mevion Expands Proton Therapy Access with MEVION S250-FIT™ in Multidisciplinary Care Setting
Dana-Farber to Expand Advanced Cancer Care with Installation of Mevion’s Compact Proton Therapy System The landscape of cancer treatment continues to evolve as healthcare providers increasingly adopt advanced technologies designed to improve patient outcomes while minimizing treatment-related side effects. In…
Healthcare Leaders Unite to Launch Groundbreaking Women’s Health AI Consortium
Health Executives Partner to Create Pioneering Women’s Health AI Initiative The women’s health industry is entering a transformative new era with the launch of the Women’s Health AI Consortium, a groundbreaking initiative created to establish the first clinically rigorous and…
STAAR Surgical Reports Q1 2026 Results, Releases Shareholder Letter
STAAR Surgical Reports Strong First Quarter 2026 Results With Record Sales and Return to Profitability STAAR Surgical Company reported record first quarter 2026 financial results, highlighting significant revenue growth, improved profitability, and continued momentum for its EVO family of Implantable…
HeartBeam Announces First Quarter 2026 Financial Results
HeartBeam Reports Strong First Quarter 2026 Progress as Commercial Expansion and AI-Driven Cardiac Innovation Accelerate HeartBeam, a medical technology company focused on transforming cardiac care through advanced ECG-based solutions, reported financial and operational results for the first quarter ended March…
Turn Therapeutics Announces Q1 2026 Financial Results and Corporate Updates
Turn Therapeutics Publishes First Quarter 2026 Results Alongside Company Updates Turn Therapeutics a clinical-stage biotechnology company focused on developing targeted inflammatory and immunological therapies for dermatologic diseases, has reported its financial results for the first quarter ended March 31, 2026,…